Bone Disorder Drugs
Bone disorder drugs are medicines used to treat diseases that weaken the bones.
The drugs described here are used to treat or prevent osteoporosis (brittle bone disease) in women past menopause as well as older men. They also are used prescribed for Paget's disease, a painful condition that weakens and deforms bones, and they are used to control calcium levels in the blood.
Bone is living tissue. Like other tissue, bone is constantly being broken down and replaced with new material. Normally, there is a balance between the breakdown of old bone and its replacement with new bone. But when something goes wrong with the process, bone disorders may result.
Osteoporosis is a particular concern for women after menopause, as well as for older men. In osteoporosis, the inside of the bones become porous and thin. Over time, this condition weakens the bones and makes them more likely to break. Osteoporosis is four times more common in women than in men. This is because women have less bone mass than men, tend to live longer and take in less calcium, and need the female hormone estrogen to keep their bones strong. If men live long enough, they are also at risk of getting osteoporosis later in life. Once total bone mass has peaked— around age 35—all adults start to lose it. In women, the rate of bone loss speeds up during menopause, when estrogen levels fall. Bone loss may also occur if both ovaries are removed by surgery. Ovaries make estrogen. Hormone replacement therapy is one approach to preventing osteoporosis. However, not all people can use hormone replacement therapy. Bone disorder drugs are a good alternative for people who already have osteoporosis or who are at risk of developing it. Risk factors include lack of regular exercise, early menopause, being underweight, and a strong family history of osteoporosis.
Bone disorder drugs are available only with a physician's prescription and come in tablet, nasal spray, and injectable forms. Commonly used bone disorder drugs are alendronate (Fosamax), calcitonin (Miacalcin, Calcimar), and raloxifene (Evista). Raloxifene belongs to a group of drugs known as selective estrogen receptor modulators (SERMs), which act like estrogen in some parts of the body but not in others. This makes the drugs less likely to cause some of the harmful effects that estrogen may cause. Unlike estrogen, raloxifene does not increase the risk of breast cancer. In fact, research suggests that raloxifene may even reduce that risk.
FOR OSTEOPOROSIS. The usual dose is 10 mg once a day. Treatment usually continues over many years.
FOR PAGET'S DISEASE. The usual dose is 40 mg once a day for six months.
This medicine works only when it is taken with a full glass of water first thing in the morning, at least 30 minutes before eating or drinking anything or taking any other medicine. Do not lie down for at least 30 minutes after taking it because the drug can irritate the esophagus, the tube that delivers food form the mouth to the stomach.
Taking aspirin with alendronate may increase the chance of upset stomach, especially if the dose of alendronate is more than 10 mg per day. If an analgesic is
Some calcium supplements, antacids and other medicines keep the body from absorbing alendronate. To prevent this problem, do not take any other medicine within 30 minutes of taking alendronate.
General precautions for bone disorder drugs
To keep bones strong, the body needs calcium and vitamin D. Dairy products and fish such as salmon, sardines and tuna are good sources of both calcium and vitamin D. People who are taking bone disorder drugs for osteoporosis and who do not get enough of these nutrients in their diets should check with their physicians about taking supplements. Other important bone-saving steps are avoiding smoking and alcohol and getting enough of the kind of exercise that puts weight on the bones (such as walking or lifting weights).
People who are taking these drugs because they have too much calcium in their blood may need to limit the amount of calcium in their diets. Too much calcium may prevent the medicine from working properly. Discuss the proper diet with the physician who prescribed the drug, and do not make any diet changes without the physician's approval.
Anyone who has had unusual reactions to bone disorder drugs in the past should let his or her physician know before taking the drugs again. The physician also should be told about any allergies to foods, dyes, preservatives, or other substances.
Women who are pregnant or who may become pregnant and women who are breastfeeding should check with their physicians before using this alendronate or calcitonin. Raloxifene should not be used by women who are pregnant or who may become pregnant. In laboratory studies of rats, raloxifene caused birth defects.
Foundation For Osteoporosis Research & Education. (888) 266-3015. <http://www.fore.org>.
National Association for the Relief of Paget's Disease. <http://www.demon.co.uk/narpd>.
National Osteoporosis Foundation 1150 17th Street NW Suite 500 Washington, D.C. 20036-4603. <http://www.nof.org>.
Estrogen—The main sex hormone that controls normal sexual development in females. During the menstrual cycle, estrogen helps prepare the body for possible pregnancy.
Fracture—A break or crack in a bone.
Hormone—A substance that is produced in one part of the body, then travels through the bloodstream to another part of the body where it has its effect.
Menopause—The stage in a woman's life when the ovaries stop producing egg cells at regular times and menstruation stops.
Osteoporosis—A disease in which bones become very porous and weak. The bones are then more likely to fracture and take longer to heal. The condition is most common in women after menopause but can also occur in older men.